These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37239922)

  • 1. The Role of Steroidomics in the Diagnosis of Alzheimer's Disease and Type 2 Diabetes Mellitus.
    Vaňková M; Velíková M; Vejražková D; Včelák J; Lukášová P; Rusina R; Vaňková H; Jarolímová E; Kancheva R; Bulant J; Horáčková L; Bendlová B; Hill M
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evidence of altered steroidogenesis in women with Alzheimer's disease: Have the patients "OLDER" adrenal zona reticularis?
    Vaňková M; Hill M; Velíková M; Včelák J; Vacínová G; Dvořáková K; Lukášová P; Vejražková D; Rusina R; Holmerová I; Jarolímová E; Vaňková H; Kancheva R; Bendlová B; Stárka L
    J Steroid Biochem Mol Biol; 2016 Apr; 158():157-177. PubMed ID: 26704533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.
    Karki R; Kodamullil AT; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus.
    Tiribuzi R; Orlacchio A; Crispoltoni L; Maiotti M; Zampolini M; De Angeliz M; Mecocci P; Cecchetti R; Bernardi G; Datti A; Martino S; Orlacchio A
    J Alzheimers Dis; 2011; 24(4):785-97. PubMed ID: 21321400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 11β-hydroxyandrostenedione pathway and C11-oxy C
    du Toit T; Swart AC
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105497. PubMed ID: 31626910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
    Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in neuroactive steroid levels in 3xTg-AD mice.
    Caruso D; Barron AM; Brown MA; Abbiati F; Carrero P; Pike CJ; Garcia-Segura LM; Melcangi RC
    Neurobiol Aging; 2013 Apr; 34(4):1080-9. PubMed ID: 23122920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes.
    Mahboobi H; Golmirzaei J; Gan SH; Jalalian M; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):543-52. PubMed ID: 24365186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An LC-MS/MS method for the simultaneous quantification of 32 steroids in human plasma.
    Šimková M; Kolátorová L; Drašar P; Vítků J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123294. PubMed ID: 35623176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies.
    Diniz Pereira J; Gomes Fraga V; Morais Santos AL; Carvalho MDG; Caramelli P; Braga Gomes K
    J Neurochem; 2021 Mar; 156(6):753-776. PubMed ID: 32909269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
    Klimova B; Kuca K; Maresova P
    Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus.
    Tang Y; Li YM; Zhang M; Chen YQ; Sun Q
    Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases.
    Caberlotto L; Nguyen TP; Lauria M; Priami C; Rimondini R; Maioli S; Cedazo-Minguez A; Sita G; Morroni F; Corsi M; Carboni L
    Sci Rep; 2019 Mar; 9(1):3965. PubMed ID: 30850634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.
    Asih PR; Tegg ML; Sohrabi H; Carruthers M; Gandy SE; Saad F; Verdile G; Ittner LM; Martins RN
    J Alzheimers Dis; 2017; 59(2):445-466. PubMed ID: 28655134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer's Disease Pathology Precursors.
    Bonds JA; Shetti A; Bheri A; Chen Z; Disouky A; Tai L; Mao M; Head BP; Bonini MG; Haus JM; Minshall RD; Lazarov O
    J Neurosci; 2019 Oct; 39(43):8576-8583. PubMed ID: 31527120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways and genes involved in steroid hormone metabolism in male pigs: a review and update.
    Robic A; Faraut T; Prunier A
    J Steroid Biochem Mol Biol; 2014 Mar; 140():44-55. PubMed ID: 24239507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults.
    Redondo MT; Beltrán-Brotóns JL; Reales JM; Ballesteros S
    Exp Gerontol; 2016 Oct; 83():47-55. PubMed ID: 27451340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline.
    Chornenkyy Y; Wang WX; Wei A; Nelson PT
    Brain Pathol; 2019 Jan; 29(1):3-17. PubMed ID: 30106209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.